By Bobby Yazdani, Founder and Managing Partner, Cota Capital

My father was a surgeon, and my mother was a nurse, so I have always been aware of the profound impact healthcare advancements can have on people’s lives. This personal connection, combined with a desire to make a difference, led Cota Capital to invest in Vave from its very earliest days.

Vave’s value proposition is clear: delivering high-quality, simple-to-use, affordable ultrasound solutions that provide crucial clinical information anywhere, anytime, thus improving patient health.

The place where Vave is making a difference is point-of-care ultrasound (POCUS). Ultrasound is a critical technology that can help diagnose and monitor many medical conditions, but its widespread adoption has been limited by several factors.

For starters, ultrasound machines have traditionally been large, heavy, and expensive, limiting their usefulness in various healthcare settings. Additionally, ultrasound equipment often requires specialized training, and there is currently a shortage of qualified personnel capable of operating these devices and interpreting the results accurately.

I was drawn to Vave because the company presented a compelling vision that addressed these challenges. With its proprietary technology in image formation and processing, along with innovative concepts like utilizing off-the-shelf components, Vave is delivering high-quality, accessible, and affordable ultrasound solutions for clinicians globally. 

Vave’s wireless, pocket-sized ultrasound solution provides a simplified buying experience with a standard 3-year warranty, no subscription fees, and an incredibly competitive price point. With Vave, clinicians who previously lacked access to bedside imaging now have an easy-to-use, handheld ultrasound platform to diagnose and treat their patients quickly and accurately. Vave also works on Android and iOS phones and tablets. That means clinicians can conveniently scan their patients using their own mobile devices and get the results they need.

Making Waves in Medical Education

Another area where Vave is making significant strides is in the medical education market. The number of medical schools with ultrasound training continues to grow, especially as the technology becomes increasingly prevalent across various specialties. Indeed, more and more medical schools require ultrasound training for their students. However, many schools still lack established curricula for ultrasound training, and faculty members often lack the necessary expertise to teach these skills effectively.

That’s why Vave is focused on integrating ultrasound education into medical schools and residency programs. For instance, the company is consulting with deans and faculty to identify and assess barriers. They are also providing “train the trainer” sessions for faculty development, as well as creating customized curricula for individual schools. Additionally, Vave is supporting overtaxed faculty by providing students with direct feedback on imaging assignments.

In short, Vave is making sure that medical educators and students have a complete solution they need to be successful with ultrasound technology.

The Future of Medical Imaging and AI

The medical industry’s interest in AI is expanding, and Vave is at the forefront of this revolution. In particular, AI-powered ultrasound offers significant advantages for new users of the technology. One key feature is the AI guidance system, which acts as a virtual bedside teacher. This system directs users on proper probe placement and beam adjustment, enabling even non-experts to capture clinically useful images.

For intermediate-level users who may not need step-by-step guidance, this tool is also valuable. It allows them to understand their own limitations and recognize when an image lacks sufficient clinical information to be helpful. Thanks to these AI-assisted features, Vave is making ultrasound technology more accessible, user-friendly, and accurate.

Image interpretation is the next crucial step in ultrasound technology. AI assistance can serve as a valuable “co-pilot” for physicians, especially those who may lack confidence in interpreting ultrasound results on their own despite having adequate training. Research has shown that AI can often outperform even the expert human eye in analyzing complex medical imaging data.

I am also encouraged to see that AI partners are eager to collaborate with Vave, which is helping to enhance the effectiveness and reach of their technologies. Overall, I’m excited about Vave’s potential to make the world a better, healthier place. It’s clear that training future medical professionals with this handheld technology will ultimately lead to improved patient care.

As an investor and advisor, I’ve supported Vave from the start because of its advanced technology, strategic vision, and passionate leadership. I believe the company is poised to transform the POCUS market and expand its influence in other areas of healthcare. By providing a complete ultrasound solution for the next generation of healthcare professionals and making it available anywhere, anytime, Vave can ultimately help save more lives.